Atlas Trials

Study to Evaluate the Safety and Efficacy of Denosumab and Actonel® in Post Menopausal Women Transitioned From Alendronate Therapy

Clinical trial NCT00919711 · COMPLETED

Trial details

NCT number
NCT00919711
Sponsor
Amgen
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Osteoporosis
Start date
2009-09-01
Primary completion
2011-12-21
Enrollment
870

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.